title: [Beta-hemolytic streptococcal bacteremia in adults].
abstract: The serogroups A (Streptococcus pyogenes), B (Streptococcus agalactiae) and S. dysgalactiae subsp. equisimilis (group C and G) are generally defined as beta-hemolytic streptococci. Beta-hemolytic streptococci cause a variety of infections ranging from skin and soft-tissue infections to severe invasive infections such as necrotizing fasciitis (NF) and streptococcal toxic shock syndrome (STSS). The case fatality rate due to bacteremias caused by beta-hemolytic streptococci is 15%. The use of clindamycin in combination with benzylpenicillin has been shown to be of benefit. The use of intravenous immunoglobulin is suggested in STSS in combination with antibiotics and surgery.
authors: TAYS, sisätautien klinikka.
authors: Sari
authors: S
authors: Rantala
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000382:microbiology / Q000401:mortality / Q000628:therapy; D002981:Clindamycin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D019115:Fasciitis, Necrotizing / Q000382:microbiology / Q000401:mortality / Q000628:therapy; D006801:Humans; D010400:Penicillin G / Q000627:therapeutic use; D012772:Shock, Septic / Q000382:microbiology / Q000401:mortality / Q000628:therapy; D013290:Streptococcal Infections / Q000382:microbiology* / Q000401:mortality / Q000628:therapy; D013292:Streptococcus agalactiae; D013297:Streptococcus pyogenes
chemical_list: D000900:Anti-Bacterial Agents; D002981:Clindamycin; D010400:Penicillin G